World Antibiotic Awareness Week14 November, 2016
November 14-20, 2016
bioMérieux is proud to help raise awareness of the global issue of antibiotic resistance by supporting World Antibiotic Awareness Week.
Our company has a long-standing commitment to the fight against antibiotic resistance. Our leadership in this field has been recognized through invitations to join the White House Forum on Antibiotic Stewardship in 2015 and the recent UN High-Level Meeting on Antimicrobial Resistance in 2016. On both occasions, our company was represented by Mark Miller, MD, FRCPC, Chief Medical Officer of bioMérieux.
Find out how bioMérieux is supporting Antibiotic Resistance Awareness in 2016
A new bioMérieux educational website on Antimicrobial Resistance (AMR)
Accessible – interactive – educational !
Education and raising awareness are the main objectives of this new website, which reaffirms bioMérieux’s longstanding commitment to antibiotic resistance and antibiotic stewardship, and highlights the medical value of diagnostics to fight against antibiotic resistance.
The website addresses multiple audiences, from scientists to healthcare providers and to the lay public, and its contents will be regularly and frequently updated as new developments on antimicrobial resistance occur.
A Global Prevalence Survey to assess Antibiotic Consumption and Resistance rates
First Global Point Prevalence Survey (Global-PPS) of Hospital Antibiotic Use and Resistance
This first global initiative provides a unique overview of the global burden of antibiotic consumption and resistance rates. Data collected from over 100,000 patients worldwide confirms the strong correlation between antibiotic use and bacterial resistance rates and reveals that:
► more than 1 out of 3 hospitalized patients receives antibiotics
► yet diagnostic tests were only performed in 1 out of 3 cases to support the chosen antimicrobial prescription
These findings raise awareness on the urgent need and benefits of setting up Antimicrobial Stewardship Programs in hospitals to curb resistance.
They also highlight the significant medical value of in vitro diagnostics and the need for more diagnostic tests and improved antimicrobial prescribing practices in all countries.
► bioMérieux and Antwerp University unveil the final results of the first Global Point Prevalence Survey of antibiotic use and resistance rates in hospitals
Following the success of the first edition and thanks to bioMérieux’s sponsorship, the Global PPS will be repeated in 2017.
► Join the Global-PPS initiative and take part in a new survey in 2017:
A comprehensive offer to curb Antibiotic Resistance
As world leader in microbiology, bioMérieux is dedicated to helping clinical labs provide actionable results faster, because time-to-diagnosis and therapeutic efficacy are paramount to infection control, preventing and managing multi-drug resistance and improving patient outcomes.
Our high-medical value diagnostic tests enable timely detection and diagnosis of healthcare-associated and multi-drug resistant infections.
bioMérieux provides clinical laboratories with a wide range of diagnostic solutions for effective screening, infection control, outbreak management and appropriate antibiotic therapy guidance.